2022-10-13 Purchase | 2022-10-17 4:42 pm | Axcella Health Inc. | AXLA | Flagship Ventures Fund IV General Partner LLC Flagship Ventures Fund IV L.P. Flagship Ventures Opportunities Fund I General Partner LLC Flagship Ventures Opportunities Fund I L.P. AFEYAN NOUBAR 10% Owner | 10,383,760 | $1.64 | $17,029,366 | 8,850,296 (Indirect) | View |
2022-05-27 Purchase | 2022-06-01 7:00 pm | Evelo Biosciences Inc. | EVLO | Flagship Ventures Fund IV General Partner LLC Flagship Ventures Fund IV L.P. Flagship Ventures Fund IV-Rx L.P. Flagship Ventures Opportunities Fund I General Partner LLC Flagship Ventures Opportunities Fund I L.P. Nutritional Health LTP Fund General Partner LLC Nutritional Health LTP Fund L.P. Flagship Pioneering Inc. AFEYAN NOUBAR 10% Owner | 27,397,259 | $1.46 | $39,999,998 | 27,233,921 (Indirect) | View |
2022-03-16 Purchase | 2022-03-18 08:30 am | Axcella Health Inc. | AXLA | Flagship Ventures Fund IV General Partner LLC Flagship Ventures Fund IV L.P. Flagship Ventures Fund IV-Rx L.P. Flagship Ventures Opportunities Fund I General Partner LLC Flagship Ventures Opportunities Fund I L.P. AFEYAN NOUBAR 10% Owner | 6,319,371 | $1.91 | $12,069,999 | 8,262,725 (Indirect) | View |
2021-03-19 Purchase | 2021-03-23 5:30 pm | Rubius Therapeutics Inc. | RUBY | Flagship Ventures Fund IV General Partner LLC Flagship Ventures Fund IV L.P. Flagship Ventures Fund V General Partner LLC Flagship Ventures Fund V L.P. Flagship Ventures Opportunities Fund I General Partner LLC Flagship Ventures Opportunities Fund I L.P. AFEYAN NOUBAR 10% Owner | 210,000 | $29 | $6,090,000 | 17,253,519 (Indirect) | View |
2021-02-08 Purchase | 2021-02-10 5:30 pm | Kaleido Biosciences Inc. | KLDO | Flagship Ventures Fund IV General Partner LLC Flagship Ventures Fund IV L.P. Flagship Ventures Opportunities Fund I General Partner LLC Flagship Ventures Opportunities Fund I L.P. Nutritional Health LTP Fund General Partner LLC Nutritional Health LTP Fund L.P. AFEYAN NOUBAR 10% Owner | 215,000 | $11.5 | $2,472,500 | 14,907,627 (Indirect) | View |
2021-02-02 Purchase | 2021-02-04 5:56 pm | Evelo Biosciences Inc. | EVLO | Flagship Ventures Fund IV General Partner LLC Flagship Ventures Fund IV L.P. Flagship Ventures Fund IV-Rx L.P. Flagship Ventures Opportunities Fund I General Partner LLC Flagship Ventures Opportunities Fund I L.P. Nutritional Health LTP Fund General Partner LLC Nutritional Health LTP Fund L.P. AFEYAN NOUBAR 10% Owner | 130,000 | $15 | $1,950,000 | 17,660,752 (Indirect) | View |
2020-10-27 Purchase | 2020-10-29 4:58 pm | Foghorn Therapeutics Inc. | FHTX | Flagship Ventures Fund V General Partner LLC Flagship Ventures Opportunities Fund I General Partner LLC Flagship Pioneering Special Opportunities Fund II General Partner LLC Flagship Ventures Fund V L.P. Flagship Ventures Opportunities Fund I L.P. Flagship Pioneering Special Opportunities Fund II L.P. Flagship Pioneering Inc. AFEYAN NOUBAR 10% Owner | 150,000 | $16 | $2,400,000 | 1,851,801 (Indirect) | View |
2020-06-29 Purchase | 2020-07-01 5:24 pm | Evelo Biosciences Inc. | EVLO | Flagship Ventures Fund IV General Partner LLC Flagship Ventures Fund IV L.P. Flagship Ventures Fund IV-Rx L.P. Flagship Ventures Opportunities Fund I General Partner LLC Flagship Ventures Opportunities Fund I L.P. AFEYAN NOUBAR 10% Owner | 4,666,666 | $3.75 | $17,499,998 | 17,614,323 (Indirect) | View |
2020-06-04 Purchase | 2020-06-08 4:46 pm | Kaleido Biosciences Inc. | KLDO | Flagship Ventures Fund IV General Partner LLC Flagship Ventures Fund IV L.P. Flagship Ventures Opportunities Fund I General Partner LLC Flagship Ventures Opportunities Fund I L.P. AFEYAN NOUBAR 10% Owner | 2,000,000 | $7.5 | $15,000,000 | 14,835,960 (Indirect) | View |
2020-05-18 Purchase | 2020-05-20 5:15 pm | Axcella Health Inc. | AXLA | Flagship Ventures Fund IV General Partner LLC Flagship Ventures Fund IV L.P. Flagship Ventures Fund IV-Rx L.P. Flagship Ventures Opportunities Fund I General Partner LLC Flagship Ventures Opportunities Fund I L.P. AFEYAN NOUBAR 10% Owner | 3,800,000 | $4.75 | $18,050,000 | 6,682,882 (Indirect) | View |